• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Rescheduled Midcycle Meeting Email, April 15, 2009, Anascorp

From:                     Brony, Michael
Sent:                      Wednesday, April 15, 2009 3:54 PM
To:                         Cordaro, Debbie
Subject:                 RE: Rescheduled Midcycle Meeting;STN 125335/0;Bioclon;Scorpion Antivenin;

Hi Debbie,
 
This is e-mail is to let you know that the proprietary name review for Anascorp BLA 125335/0 is ongoing and will be completed by the May 22nd PDUFA date.
 
Thanks
 
Michael
 
_____________________________________________
From:                     Cordaro, Debbie 
Sent:                      Wednesday, April 15, 2009 3:46 PM
To:                          Fisher, Robert; Brony, Michael; Frazier, Douglas; Kennedy, Michael; Ko, Hon Sum; Mahmood, Iftekhar; Ou, Alan C.; Wesley, Robert; Zhang, Pei; Zinderman, Craig E; Beren, Joel; Lin, Xue; Ward- Peralta, Cherie
Cc:                          Jain, Nisha; Gupta, Ghanshyam; Scott, Dorothy
Subject:                Rescheduled Midcycle Meeting;STN 125335/0;Bioclon;Scorpion Antivenin;
 
Just a reminder that tomorrow is our midcycle meeting. As of a few minutes ago, there have been very few memos uploaded to the EDR. After tomorrow's meeting I will need to provide the OBRR management the status of this committee, i.e., who has submitted their memos. Please make every effort to complete your memo before we meet.

See you tomorrow,
Debbie
 
 
Debbie Cordaro
 
Debbie Cordaro
Regulatory Project Manager
OBRR
Voice: 301-827-6157 Fax 301-827-2857
debbie.cordaro@fda.hhs.gov